Quick Search

 

 


 

 

Result Summary for 113893

Result Summary
Protocol ID: 113893
Clinical Study ID: EGF113893
Official Title: PGx132 lapatinib diarrhea pharmacogenetics in EGF10009, EGF100151, EGF10021, EGF10023, EGF102580, EGF102980, EGF103009, EGF104900, EGF105084, EGF105764, EGF20009, EGF20014, EGF30001 and VEG20007
Phase: n\a
Study Indications or Diseases:
  • Neoplasms, Breast
Generic Name: lapatinib
Trade/Product Name: Tykerb,Tycerb,Tyverb
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.